News
A wave of public alarm over counterfeit and dangerous foreign-made prescription drugs, particularly from China, has reached new heights, according to a recent ...
Cencora is one of three leading domestic wholesalers of branded, generic, and specialty pharmaceutical products. With over $250 billion in annual US healthcare distribution sales, the company supplies ...
You could be making all the right food choices, but still feel off if your timing is inconsistent. Reisdorf sees this all the ...
Novo Nordisk’s outgoing CEO, Lars Fruergaard Jorgensen, has warned that layoffs at the Danish pharmaceutical giant could be ...
The biotech company extends its Phase I trial (NCT06252220) of DA-1726 to eight weeks following encouraging early efficacy, ...
Linda Yaccarino, the former X CEO who left the social media company last month in the wake of yet another Elon Musk ...
As the list of health benefits of semaglutide drugs grows, perhaps it is time to think about assessing their impact on people without medical conditions ...
Cencora, Inc. (NYSE:COR) on Wednesday reported third-quarter 2025 sales increased 8.7% to $80.66 billion, beating the consensus of $80.354 billion. Sales increased due to an 8.5% increase in revenue ...
Nearly 12% of Americans have used GLP-1 drugs for weight loss, including about one-fifth of women aged 50 to 64, according to ...
2h
News-Medical.Net on MSNRAND study highlights patterns of GLP-1 medication use and side effectsNearly 12% of Americans have used GLP-1 drugs for weight loss, including about one-fifth of women aged 50 to 64, according to ...
Claire Reed bought medication online to lose weight before a vacation, but claims she was passing out and too nauseous to eat ...
Hims & Hers Health showed a sharper-than-expected revenue hiccup in Q2, sending the stock down. Click here to find out why ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results